571 |
BioMatrixTM: The New Biodegradable Abluminally Coated DES BioMatrixTM Clinical Program |
Teguh Santoso |
Jul. 22. 09 |
570 |
Asia Pacific BioMatrixTM Clinical Results |
Teguh Santoso |
Jul. 22. 09 |
569 |
LEADERS: Analysis of 9 Months OCT Results |
Patrick W. Serruys |
Jul. 22. 09 |
568 |
Assessment of LEADERS 12 Months Result |
Patrick W. Serruys |
Jul. 22. 09 |
567 |
AMI Intervention in DES Era and Beyond |
Harry Suryapranata |
Jul. 22. 09 |
566 |
Genous Stent in Real-World Experience and TRIAS HR Pilot Study Long Term Follow Up |
Margo Klomp |
Jul. 22. 09 |
565 |
Development of a Novel Sirolimus Eluting Pro-Healing Stent |
Juan F. Granada |
Jul. 22. 09 |
564 |
Interventional Definition of True and False Lumen |
Masahiko Ochiai |
Jul. 21. 09 |
563 |
Emerging Technologies |
Ron Waksman |
Jul. 21. 09 |
562 |
Stents |
Barry D. Rutherford |
Jul. 21. 09 |